Drug
Chf6001 Dpi
Chf6001 Dpi: highest development phase Phase 1, developed by Chiesi Farmaceutici. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Chiesi Farmaceutici
Trials
| Drug | Phase | Indication |
|---|---|---|
| CHF6001 DPI NCT06395610 | Phase 1 | Chronic Obstructive Pulmonary Disease |
Latest
No recent events.
Follow Chf6001 Dpi on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.